Journal of Neuroimmunology
Volume 218, Issue 1 , Pages 125-128 , 25 January 2010

An atypical case of X-linked lymphoproliferative disease revealed as a late cerebral lymphoma

  • B. Hervier

      Affiliations

    • Internal Medicine Department, CHU NANTES, Place Alexis Ricordeau, 44093 Nantes, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 2 40 08 33 55; fax: +33 2 40 8 33 79.
  • ,
  • S. Latour

      Affiliations

    • Unité Inserm U768, Hopital Necker-Enfants-Malades, 75015 Paris, France
  • ,
  • D. Loussouarn

      Affiliations

    • Pathology Department, CHU NANTES, France
  • ,
  • M. Rimbert

      Affiliations

    • Laboratory of Immunology, CHU NANTES, France
  • ,
  • G De-Saint-Basile

      Affiliations

    • Unité Inserm U768, Hopital Necker-Enfants-Malades, 75015 Paris, France
  • ,
  • C. Picard

      Affiliations

    • Unité Inserm U768, Hopital Necker-Enfants-Malades, 75015 Paris, France
  • ,
  • M. Hamidou

      Affiliations

    • Internal Medicine Department, CHU NANTES, Place Alexis Ricordeau, 44093 Nantes, France

Received 3 August 2009 ,Revised 12 October 2009 ,Accepted 19 October 2009.

References 

  1. Aghamohammadi A, Kanegane H, Moein M, Farhoudi A, Pourpak Z, Movahedi M, et al. Identification of an SH2D1A mutation in a hypogammaglobulinemic male patient with a diagnosis of common variable immunodeficiency. Int. J. Hematol. 2003;78:45–47
  2. Grierson H, Purtilo DT. Epstein-Barr virus infections in males with the X-linked lymphoproliferative syndrome. Ann. Intern. Med. 1987;106:538–545
  3. Hugle B, Suchowerskyj P, Hellebrand H, Adler B, Borte M, Sack U, et al. Persistent hypogammaglobulinemia following mononucleosis in boys is highly suggestive of X-linked lymphoproliferative disease—report of three cases. J. Clin. Immunol. 2004;24:515–522
  4. Kanegane H, Ito Y, Ohshima K, Shichijo T, Tomimasu K, Nomura K, et al. X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis. Am. J. Hematol. 2005;78:130–133
  5. Latour S, Veillette A. Molecular and immunological basis of X-linked lymphoproliferative disease. Immunol. Rev. 2003;192:212–224
  6. Nistala K, Gilmour KC, Cranston T, Davies EG, Goldblatt D, Gaspar HB, et al. X-linked lymphoproliferative disease: three atypical cases. Clin. Exp. Immunol. 2001;126:126–130
  7. Veillette A, Dong Z, Latour S. Consequence of the SLAM-SAP signaling pathway in innate-like and conventional lymphocytes. Immunity. 2007;27:698–710
  8. Veillette A, Zhang S, Shi X, Dong Z, Davidson D, Zhong MC. SAP expression in T cells, not in B cells, is required for humoral immunity. Proc. Natl. Acad. Sci. U. S. A. 2008;105:1273–1278

PII: S0165-5728(09)00404-4

doi: 10.1016/j.jneuroim.2009.10.012

Journal of Neuroimmunology
Volume 218, Issue 1 , Pages 125-128 , 25 January 2010